ClinicalTrials.Veeva

Menu

"Pain and Emotional Changes on Relationships Between Anxiety and Olfaction"

Q

Qassim University

Status

Completed

Conditions

Anxiety

Treatments

Drug: Lavender Oil
Drug: Distal Water

Study type

Interventional

Funder types

Other

Identifiers

NCT06066073
EA/3006/2018

Details and patient eligibility

About

Introduction: This prospective study aimed to assess the impact of olfaction on providing positive emotional responses and reducing dental anxiety and pain.

Material: A randomized double-blinded controlled study was enrolled on female patients. The olfaction was stimulated via lavender essential oils. Patients were divided into lavender and control groups. Patients in lavender group inhaled 2 % lavender vapors. In control group, patients inhaled distal water vapors. The variables included pain, anxiety, and vital signs. Anxiety was measured through Modified Dental Anxiety Scale (MDAS) and Speilberger State-Trait Anxiety Inventory (STAI) questionnaires. Pain was evaluated through visual analog scales (VAS). Vital signs included the systolic (SBP) and diastolic blood pressure (DBP), heart rate (HR), respiratory rate (RR), and oxygen saturation (Spo2). All variables were assessed before the intervention, 20 minutes after inhalation of vapors, and at the end of dental settings. The last evaluation was on the day after visits. P-values < 0.05 were considered significant.

Full description

ABSTRACT:

Background: The purpose of the study was to determine to what extent olfactory aromatherapy reduces the intensity of dental pain and the level of dental anxiety. It also attempted to corelate between olfactory aromatherapy, stages of dental visits, and various dental procedures.

Methods: Female patients were enrolled in a randomized controlled study. Olfactory aromatherapy was performed using lavender oils. Patients were randomly assigned to one of two groups: the lavender group, in which patients inhaled 2% lavender vapors, and the control group, in which patients inhaled water vapors. Pain score, anxiety score, and changes in vital signs were among the predictable variables. Anxiety and pain were assessed using the Modified Dental Anxiety Scale (MDAS), Speilberger State-Trait Anxiety Inventory (STAI), and visual analog scales (VAS). The vital signs were systolic (SBP) and diastolic (DBP), heart rate (HR), respiratory rate (RR), and oxygen saturation (Spo2). Variables were evaluated before inhalations, 20 minutes after inhalations, at the end of settings, and on the following day.

Enrollment

350 patients

Sex

Female

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult females over 18 years,

  • Attending morning sessions of clinics (9 am),

  • Liable for administration of local anesthesia, tooth preparation either for:

    1. Filling procedures or crown preparations
    2. Endodontic treatment
    3. Teeth extraction
    4. Eubgingival scaling

Exclusion criteria

  • Males

  • Females who had:

    1. Allergies
    2. Bronchial asthma
    3. Common cold
    4. Pulmonary diseases
    5. Migraine
  • Females who taking:

    1. Antidepressants
    2. Anxiolytic drugs
    3. Opioids
    4. Other medications that affect emotional responses
  • Pregnant females

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

350 participants in 2 patient groups, including a placebo group

Lavender group
Experimental group
Description:
Patients who were included in this group were subjected to vapors of the lavender oil in waiting rooms, during dental therapy, and on day after dental procedures
Treatment:
Drug: Lavender Oil
Control group
Placebo Comparator group
Description:
Patients who were included in this group were subjected to vapors of distal water in waiting rooms and during dental therapy
Treatment:
Drug: Distal Water

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems